Algeria to Withdraw 108 Common Medications Amid Safety Concerns
Algeria is set to withdraw 108 medications deemed unsafe, as reported by the French medical journal "Prescrire". This announcement has raised alarms, particularly since many of these drugs are commonly used and often available without a prescription.
The withdrawal is scheduled to take effect in 2026, with the medications classified as having risks that outweigh their benefits. Some of the notable medications on the list include:
• Smecta, used for intestinal issues.
• Maxilase, for sore throat relief.
• Toplexil, a cough suppressant.
• Volgalin, for dizziness treatment.
* Public Health Concerns
The announcement has led to widespread concern among Algerians regarding the potential health risks associated with these medications, especially for those who have used them regularly.
Health expert Mohamed Kouach provided insights, stating:
"Every medication must meet safety standards concerning usage and potential side effects, both short-term and long-term. New side effects can emerge even after years of use, prompting a reassessment of risk levels."
He clarified that the inclusion of these medications on the list does not automatically classify them as dangerous. However, their risks may surpass their benefits for certain patients or in cases of overuse.
He further noted:
"Patients currently using these medications do not require specialized treatment protocols. The withdrawal aims to safeguard public health until further data or confirmation from the World Health Organization is available."
He also highlighted that excessive use of medications can lead to more significant health issues than the medications themselves.
* Key Takeaway
It is crucial for Algerians to consult healthcare professionals before taking any medication, regardless of its commonality, and to adhere to recommended dosages to prevent health complications, particularly in light of this new list of familiar medications.
